Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
From a biochemical standpoint, BPC-157 operates by influencing signaling cascades linked to angiogenesis the development of new blood vesselsand fibroblast activation
Note: TB-500 is far less studied than full-length Thymosin -4, and the following effects are primarily supported for the parent compound: Actin Binding: Sequesters G-actin monomers, regulating cytoskeletal dynamics essential for cell movement (PMID: 22074294 - Thymosin -4) Cell Migration: Enables endothelial cells, keratinocytes, and other repair cells to migrate to injury sites (PMID: 22074294 - Thymosin -4) Anti-inflammatory: Reduces inflammatory cytokines and promotes resolution of inflammation (PMID: 30116499 - Thymosin -4) Matrix Metalloproteinase Regulation: Modulates tissue remodeling enzymes for proper scar formation (PMID: 16607611 - Thymosin -4) Stem Cell Recruitment: May enhance mobilization of stem cells to damaged areas (PMID: 22074294 - Thymosin -4) Complementary Action: BPC-157 establishes the blood supply (angiogenesis) needed for healing, while TB-500 facilitates the cellular migration and tissue remodeling that follows
The FDA's compounding-related classification of BPC-157 has been the subject of significant discussion in early 2026, and the regulatory landscape may continue to evolve
Why Choose Us Independently tested by an accredited laboratory and verified at 99%+ purity
